Kailos Prevent™ for High Prevalence, Actionable Conditions

Inform Healthcare Decisions

Designed around evidence-based guidelines and recommendations from leading genetic healthcare experts, Kailos Prevent™ can identify DNA changes with significant potential for positive impact on a person's health. These genetic changes increase the risk of developing cancer, heart disease, strokes and the metabolism of antidepressants & opioids. 

Prevent Couple
Prevent Conditions

To learn more about CDC Tier 1 Genomic Applications, click here.


To see our poster presented at the 2023 Updates in Precision Medicine and
Pharmacogenomics Conference hosted by the Precision Medicine
Leaders' Summit and the University of Florida College of Pharmacy,
please click here.

Genes Targeted by Prevent

Prevent and Plus Genes
Two Ways to Utilize Prevent and Prevent Plus

Either validate the assay in your own laboratory with Kailos supplied reagents and protocols; or send out samples to our CAP/CLIA certified laboratory. In each case, our cloud based analytics system facilitates secure transfer of results.

Lab equipment

Interested in Learning More?


Please contact us below

We look forward to hearing from you!

Get In Touch


601 Genome Way
Suite 2005
Huntsville, AL  35806


9am - 5pm (Central Time)


For technical inquiries support@kailosgenetics.com